amifostine anhydrous has been researched along with Hypopharyngeal Cancer in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As for acute xerostomia, patients with laryngeal cancer were excluded from evaluation." | 2.71 | Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection? ( Fehlauer, F; Feyerabend, T; Hinke, A; Mahlmann, B; Marx, M; Richter, E; Sommer, K; Vacha, P, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vacha, P | 1 |
| Fehlauer, F | 1 |
| Mahlmann, B | 1 |
| Marx, M | 1 |
| Hinke, A | 1 |
| Sommer, K | 1 |
| Richter, E | 1 |
| Feyerabend, T | 1 |
| Kutter, J | 1 |
| Ozsahin, M | 1 |
| Monnier, P | 1 |
| Stupp, R | 1 |
1 trial available for amifostine anhydrous and Hypopharyngeal Cancer
| Article | Year |
|---|---|
Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
Topics: Amifostine; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Female; Head and Neck Neo | 2003 |
1 other study available for amifostine anhydrous and Hypopharyngeal Cancer
| Article | Year |
|---|---|
Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; C | 2005 |